Ketamine for Chronic Pain & Depression

by | Apr 6, 2018 | Articles, Chronic pain, Conditions, Intravenous therapies, Mental health

Ketamine is proving to be a tremendous treatment for intractable depression as well as chronic pain.  Our experience is consistent with most research studies, showing that about half the patients treated respond positively.

It has emerged as a treatment option for a variety of chronic pain conditions including fibromyalgia, small fiber neuropathy, Complex Regional Pain Syndrome (CRPS), Reflex Sympathetic Dystrophy (RSD) and psychiatric conditions including depression, Post Traumatic Stress Disorder (PTSD), suicidal ideation, and Obsessive-Compulsive Disorder (OCD).

Ketamine Nasal Spray

We offer in-office, medically supervised, self-administration of ketamine nasal spray which is less expensive and less invasive than IV ketamine therapy.  Ketamine nasal is absorbed very quickly, much as with IV administration.  We monitor patients for 1-2 hours after dosing of ketamine spray and they are not permitted to drive or operate machinery for the remainder of the treatment day.  Once the patient has shown they tolerate the ketamine and it works for them we then transition to the patient using the ketamine at home.

Ketamine in the News

Remarkable secrets of ketamine’s antidepressant effect unlocked by scientists

Could Party Drug Ketamine Be a Treatment for Depression?

‘The fog is gone’: How ketamine could help lift hard-to-treat depression

Ketamine Research

Ketamine for Depression, 1: Clinical Summary of Issues Related to Efficacy, Adverse Effects, and Mechanism of Action.

Ketamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms

The use of ketamine as an antidepressant: a systematic review and meta-analysis.

Ketamine safety and tolerability in clinical trials for treatment-resistant depression.

Low-dose ketamine for treatment resistant depression in an academic clinical practice setting.

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

Symptomatology and predictors of antidepressant efficacy in extended responders to a single ketamine infusion.

How does ketamine elicit a rapid antidepressant response?

Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial.

Do the dissociative side effects of ketamine mediate its antidepressant effects?

Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: a pilot randomized controlled trial.

Ketamine IV Brochure


Print Friendly, PDF & Email

Thanks for sharing this article!